June 17 (Reuters) – Aspen Pharmacare Holdings Ltd:
* USE OF DEXAMETHASONE IN THE CLINICAL MANAGEMENT OF
COVID-19 REQUIRING RESPIRATORY INTERVENTION
* ASPEN OWNS RIGHTS TO DEXAMETHASONE; DISTRIBUTES BOTH
AND/OR TABLETS CONTAINING DEXAMETHASONE IN A NUMBER OF COUNTRIES
Source text for Eikon:
Further company coverage:
© 2019 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters
or its third party content providers. Any copying, republication or redistribution of Reuters content, including
by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon.
"Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.